AGIOS PHARMACEUTICALS, INC. (AGIO) Insider Trading -- Recent Executive & Director Transactions
16 insiders reported 133 Form 4 transactions for AGIOS PHARMACEUTICALS, INC. (AGIO) over the past 18 months (most recent 2026-08-06). Recent activity: Gheuens Sarah (Chief Medical Officer) Sell 30,000 shares, Backstrom Jay T. (Director) Buy 1,447 shares, Gheuens Sarah (Chief Medical Officer) Buy 8,375 shares, Gheuens Sarah (Chief Medical Officer) Sell 4,007 shares, Ballal Rahul D. (Director) Buy 2,816 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-06 | Gheuens Sarah | Chief Medical Officer | Sell | 30,000 | $914,400 |
| 2026-07-10 | Backstrom Jay T. | Director | Buy | 1,447 | $0 |
| 2026-07-02 | Gheuens Sarah | Chief Medical Officer | Buy | 8,375 | $0 |
| 2026-07-02 | Gheuens Sarah | Chief Medical Officer | Sell | 4,007 | $150,503 |
| 2026-06-23 | Ballal Rahul D. | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Scadden David | Director | Buy | 2,816 | $0 |
| 2026-06-23 | FOUSE JACQUALYN A | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Owen Adams Catherine | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Foster-Cheek Kaye I | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Ho Maykin | Director | Buy | 2,816 | $0 |
| 2026-06-23 | CAPELLO JEFFREY D | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Smith Cynthia | Director | Buy | 2,816 | $0 |
| 2026-06-16 | Owen Adams Catherine | Director | Buy | 1,976 | $0 |
| 2026-06-16 | CAPELLO JEFFREY D | Director | Buy | 1,976 | $0 |
| 2026-04-06 | Burns James William | Chief Legal Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Milanova Tsveta | Chief Commercial Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Milanova Tsveta | Chief Commercial Officer | Sell | 3,262 | $113,224 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Buy | 25,528 | $0 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Sell | 12,472 | $432,903 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Buy | 13,500 | $0 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Sell | 6,596 | $228,947 |
| 2026-04-06 | Gheuens Sarah | Chief Medical Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Gheuens Sarah | Chief Medical Officer | Sell | 2,940 | $102,047 |
| 2026-04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Buy | 8,100 | $0 |
| 2026-04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Sell | 2,959 | $102,707 |
Source: SEC Form 4 filings · as of 2026-08-06